About Us

Our Mission

Fountain’s mission is to develop a pipeline of therapeutics that treat the underlying cause of degenerative diseases by utilizing our proprietary technology to elucidate the biology of cellular resilience. By targeting cellular resilience, we are pioneering a new way to treat the many diseases that arise from aging.

lab and team

Our Team

We are leaders in aging research and computation. Our team collaborates and combines our expertise in aging biology and computation to achieve our mission to develop novel therapeutics to treat chronic degenerative diseases.

Management

thomas rando

Thomas Rando, MD, PhD
Co-Founder, Executive Chairman, Board of Directors

anu hoey

Anupama Hoey, MSc, MBA
Chief Operating and Business Officer, Board Member

joe rodgers

Joseph Rodgers, PhD
Co-Founder, Director of Biology

tom cheung

Tom Cheung, PhD
Co-Founder

team

raj bhatnagar

Raj Bhatnagar, PhD
Associate Director of Computational Biology

derek britain

Derek Britain, PhD
Scientist

joshua chin

Joshua Chin
Operations Manager

conor corbin

Conor Corbin (PhD candidate)
Data Scientist

charles curt

Charles Curt
Software Engineer

brian hodge

Brian Hodge, PhD
Senior Scientist

bhagawati jalnapurkar

Bhagawati Jalnapurkar
Senior Research Associate

david le

David Le
In vivo Scientist

jeremy linsley

Jeremy Linsley, PhD
Associate Director of Neuroscience

fernando martinez

Fernando Martinez, PhD
Associate Director of Screening

anne pipathsouk

Anne Pipathsouk, PhD
Senior Scientist

jesse rosen

Jesse Rosen
Research Associate Computational Chemistry

will shainin

Will Shainin
ML Engineer

lynn yamamoto

Lynn Yamamoto, PhD
Director of Translation

ryan zarcone

Ryan Zarcone, PhD
Associate Director of Data Science

Board of Directors

Thomas Rando, MD, PhD
Co-Founder, Executive Chairman, Board of Directors
Ash Khanna, PhD, MBA
Partner, Pivotal bioVenture Partners (US)
Alex Morgan, MD, PhD
Partner, Khosla Ventures
Anupama Hoey, MSc, MBA
Chief Operating and Business Officer, Board Member

Scientific Advisory Board

Eric Verdin, MD
CEO of the Buck Institute
Mike Cancro, PhD
Prof of Immunology UPENN
(immunology and aging of the immune system)
Gordon Ringold, PhD
Biotech Exec, founder Maxygen, founder Alexza
(legacy member, company building entrepreneur)
Andrew Trister, MD, PhD
Head of AI/Digital at Gates Foundation
(ex-Apple head medical): applications beyond drug discovery 

Investors

khosla-ventures logo
nan-fung-life-sciences logo
lilly-company logo
alexandria-venture-investments logo

Collaborators

Fountain and Lilly have entered into an agreement, enabled through Lilly’s Innovation Solutions, for Fountain to screen Lilly’s novel proprietary compounds in Fountain’s platform with an in-licensing option for Fountain’s future development.

lilly-company logo